The Efficacy of Bepotastine Besilate Compared with Hydroxyzine Pamoate for Preventing Infusion Reactions with First Dose of Rituximab in Non-Hodgkin Lymphoma Patients: Protocol for a Phase II, Double-Blind, Multicenter, and Randomized Trial (Preprint)
Author:
Kitahiro YumiORCID,
Yamamoto KazuhiroORCID,
Yakushijin KimikazuORCID,
Ioroi TakeshiORCID,
Tanda MasaakiORCID,
Itohara KotaroORCID,
Omura TomohiroORCID,
Minami HironobuORCID,
Yano IkukoORCID
Publisher
JMIR Publications Inc.